BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 20005186)

  • 21. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
    Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
    Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis.
    Zhu X; Ding M; Yu ML; Feng MX; Tan LJ; Zhao FK
    BMC Cancer; 2010 Jun; 10():290. PubMed ID: 20546628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomics analysis of human breast milk by two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) coupled with mass spectrometry to assess breast cancer risk.
    Aslebagh R; Whitham D; Channaveerappa D; Lowe J; Pentecost BT; Arcaro KF; Darie CC
    Electrophoresis; 2023 Jul; 44(13-14):1097-1113. PubMed ID: 36971330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic profiling of mammary carcinomas identifies C7orf24, a gamma-glutamyl cyclotransferase, as a potential cancer biomarker.
    Gromov P; Gromova I; Friis E; Timmermans-Wielenga V; Rank F; Simon R; Sauter G; Moreira JM
    J Proteome Res; 2010 Aug; 9(8):3941-53. PubMed ID: 20527979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic profiling of human retinal and choroidal endothelial cells reveals molecular heterogeneity related to tissue of origin.
    Zamora DO; Riviere M; Choi D; Pan Y; Planck SR; Rosenbaum JT; David LL; Smith JR
    Mol Vis; 2007 Oct; 13():2058-65. PubMed ID: 18079679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thymidine phoshorylase expression in breast cancer: the prognostic significance and its association with other angiogenesis related proteins and extracellular matrix components.
    Ioachim E
    Histol Histopathol; 2008 Feb; 23(2):187-96. PubMed ID: 17999375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative proteomic study identified calreticulin and prohibitin up-regulated in adrenocortical carcinomas.
    Yang MS; Wang HS; Wang BS; Li WH; Pang ZF; Zou BK; Zhang X; Shi XT; Mu DB; Zhang DX; Gao YS; Sun XW; Xia SJ
    Diagn Pathol; 2013 Apr; 8():58. PubMed ID: 23587357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.
    De Brot M; Rocha RM; Soares FA; Gobbi H
    Pathology; 2012 Jun; 44(4):303-12. PubMed ID: 22544210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative proteomic analysis of different stages of breast cancer tissues using ultra high performance liquid chromatography tandem mass spectrometer.
    Al-Wajeeh AS; Salhimi SM; Al-Mansoub MA; Khalid IA; Harvey TM; Latiff A; Ismail MN
    PLoS One; 2020; 15(1):e0227404. PubMed ID: 31945087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection.
    Garczyk S; von Stillfried S; Antonopoulos W; Hartmann A; Schrauder MG; Fasching PA; Anzeneder T; Tannapfel A; Ergönenc Y; Knüchel R; Rose M; Dahl E
    PLoS One; 2015; 10(4):e0122106. PubMed ID: 25875093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteome of metastatic canine mammary carcinomas: similarities to and differences from human breast cancer.
    Klopfleisch R; Klose P; Weise C; Bondzio A; Multhaup G; Einspanier R; Gruber AD
    J Proteome Res; 2010 Dec; 9(12):6380-91. PubMed ID: 20932060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomic analysis of ovarian cancer proximal fluids: validation of elevated peroxiredoxin 1 in patient peripheral circulation.
    Hoskins ER; Hood BL; Sun M; Krivak TC; Edwards RP; Conrads TP
    PLoS One; 2011; 6(9):e25056. PubMed ID: 21980378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma.
    Leek RD; Landers R; Fox SB; Ng F; Harris AL; Lewis CE
    Br J Cancer; 1998 Jun; 77(12):2246-51. PubMed ID: 9649140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mass spectrometry (LC-MS/MS) identified proteomic biosignatures of breast cancer in proximal fluid.
    Whelan SA; He J; Lu M; Souda P; Saxton RE; Faull KF; Whitelegge JP; Chang HR
    J Proteome Res; 2012 Oct; 11(10):5034-45. PubMed ID: 22934887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma.
    Celis JE; Gromov P; Cabezón T; Moreira JM; Friis E; Jirström K; Llombart-Bosch A; Timmermans-Wielenga V; Rank F; Gromova I
    Mol Cell Proteomics; 2008 Oct; 7(10):1795-809. PubMed ID: 18632593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Strategy to Investigate Tissue-Secreted Tumor Microenvironmental Proteins in Serum toward Development of Breast Cancer Early Diagnosis Biomarker Signature.
    Pendharkar N; Dhali S; Abhang S
    Proteomics Clin Appl; 2019 May; 13(3):e1700119. PubMed ID: 30281209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-throughput screening of saliva for early detection of oral cancer: a pilot study.
    Szanto I; Mark L; Bona A; Maasz G; Sandor B; Gelencser G; Turi Z; Gallyas F
    Technol Cancer Res Treat; 2012 Apr; 11(2):181-8. PubMed ID: 22335413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium.
    Fox SB; Westwood M; Moghaddam A; Comley M; Turley H; Whitehouse RM; Bicknell R; Gatter KC; Harris AL
    Br J Cancer; 1996 Feb; 73(3):275-80. PubMed ID: 8562330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
    Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
    J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resolving breast cancer heterogeneity by searching reliable protein cancer biomarkers in the breast fluid secretome.
    Mannello F; Ligi D
    BMC Cancer; 2013 Jul; 13():344. PubMed ID: 23849048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.